File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Swallowing disorders following free jejunal flap reconstruction of circumferential pharyngeal defect: Does Botox help?

TitleSwallowing disorders following free jejunal flap reconstruction of circumferential pharyngeal defect: Does Botox help?
Authors
KeywordsSwallowing
Swallowing disorder
Swallowing dysfunction
Free jejunal flap
Circumferential pharyngectomy
Issue Date2020
PublisherPergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology
Citation
Oral Oncology, 2020, v. 104, p. article no. 104612 How to Cite?
AbstractObjectives: Free jejunal flap for circumferential pharyngeal reconstruction is associated with late-onset dysphagia, regurgitation and prolonged transit time. This study aims to assess the feasibility and efficacy of Botulinum toxin A (Botox) in alleviating such swallowing dysfunction. Materials and methods: Twenty-six consecutive patients underwent free jejunal flap for circumferential pharyngeal reconstruction between January 2012 and December 2018. Outcomes were compared at 6, 12 and 24 months. Results: In the non-Botox group (n = 13), video-fluoroscopic and manometry studies demonstrated asynchronous contractions and retrograde propulsion. All patients complained of nasal regurgitation on thin fluids at 6, 12 and 24 months. Bolus residue accumulation along jejunal mucosal folds resulted in prolonged transit time. In the Botox group (n = 13), amplitude of asynchronous contractions were lower: 25.4 mmHg vs. 52.1 mmHg (p = 0.037) for thin fluids at 12 months. Three patients complained of nasal regurgitation on thin fluids at 6 months. All 3 were asymptomatic at 12 months. Transit time was shortened overall. Functional Oral Intake Scale was higher. MD Anderson Dysphagia Inventory global (72.5% vs 45.7%, p = 0.003) and functional (62.0% vs 40.6%, p = 0.012) subscales were significantly improved at 24 months. Conclusion: Botox safely and effectively alleviates swallowing dysfunction associated with free jejunal flap for circumferential pharyngeal reconstruction.
Persistent Identifierhttp://hdl.handle.net/10722/284614
ISSN
2021 Impact Factor: 5.972
2020 SCImago Journal Rankings: 1.623
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChow, VLY-
dc.contributor.authorChan, JYW-
dc.contributor.authorCheng, IKY-
dc.contributor.authorChan, KMK-
dc.date.accessioned2020-08-07T09:00:10Z-
dc.date.available2020-08-07T09:00:10Z-
dc.date.issued2020-
dc.identifier.citationOral Oncology, 2020, v. 104, p. article no. 104612-
dc.identifier.issn1368-8375-
dc.identifier.urihttp://hdl.handle.net/10722/284614-
dc.description.abstractObjectives: Free jejunal flap for circumferential pharyngeal reconstruction is associated with late-onset dysphagia, regurgitation and prolonged transit time. This study aims to assess the feasibility and efficacy of Botulinum toxin A (Botox) in alleviating such swallowing dysfunction. Materials and methods: Twenty-six consecutive patients underwent free jejunal flap for circumferential pharyngeal reconstruction between January 2012 and December 2018. Outcomes were compared at 6, 12 and 24 months. Results: In the non-Botox group (n = 13), video-fluoroscopic and manometry studies demonstrated asynchronous contractions and retrograde propulsion. All patients complained of nasal regurgitation on thin fluids at 6, 12 and 24 months. Bolus residue accumulation along jejunal mucosal folds resulted in prolonged transit time. In the Botox group (n = 13), amplitude of asynchronous contractions were lower: 25.4 mmHg vs. 52.1 mmHg (p = 0.037) for thin fluids at 12 months. Three patients complained of nasal regurgitation on thin fluids at 6 months. All 3 were asymptomatic at 12 months. Transit time was shortened overall. Functional Oral Intake Scale was higher. MD Anderson Dysphagia Inventory global (72.5% vs 45.7%, p = 0.003) and functional (62.0% vs 40.6%, p = 0.012) subscales were significantly improved at 24 months. Conclusion: Botox safely and effectively alleviates swallowing dysfunction associated with free jejunal flap for circumferential pharyngeal reconstruction.-
dc.languageeng-
dc.publisherPergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology-
dc.relation.ispartofOral Oncology-
dc.subjectSwallowing-
dc.subjectSwallowing disorder-
dc.subjectSwallowing dysfunction-
dc.subjectFree jejunal flap-
dc.subjectCircumferential pharyngectomy-
dc.titleSwallowing disorders following free jejunal flap reconstruction of circumferential pharyngeal defect: Does Botox help?-
dc.typeArticle-
dc.identifier.emailChow, VLY: chowlyv@hku.hk-
dc.identifier.emailChan, JYW: jywchan1@hku.hk-
dc.identifier.authorityChan, JYW=rp01314-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.oraloncology.2020.104612-
dc.identifier.pmid32135435-
dc.identifier.scopuseid_2-s2.0-85080052298-
dc.identifier.hkuros312140-
dc.identifier.volume104-
dc.identifier.spagearticle no. 104612-
dc.identifier.epagearticle no. 104612-
dc.identifier.isiWOS:000529351800023-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1368-8375-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats